Compare McCormick & Company, Incorporated (MKC) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McCormick & Company, Incorporated vs Recursion Pharmaceuticals Inc — how do they compare? McCormick & Company, Incorporated trades at $52.01 (market cap $14.04B), while Recursion Pharmaceuticals Inc trades at $3.07 (market cap $1.53B). The key difference: McCormick & Company, Incorporated is far larger — about 9.2× Recursion Pharmaceuticals Inc's market cap, and McCormick & Company, Incorporated pays a 3.68% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| MKC | RXRX | |
|---|---|---|
Market Cap | $14.04B | $1.53B |
Sector | Consumer Staples | Health |
52-Week High | $72.81 | $6.79 |
52-Week Low | $45.60 | $2.84 |
Enterprise Value | $18.65B | $946.50M |
Dividend Yield | 3.68% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About McCormick & Company, Incorporated
In its 130-year history, McCormick has grown to become the leading global manufacturer, marketer, and distributor of spices, herbs, extracts, seasonings, and other flavorings. Beyond end consumers, McCormick's customer base also includes top quick-service restaurants, retail grocery chains, and other packaged food and beverage manufacturers, with about 30% of sales generated beyond its home turf to include 150 other countries and territories. In addition to its namesake brand, the firm's portfolio includes Old Bay, Zatarain's, Thai Kitchen, Frank's RedHot, French's, and the recently acquired Cholula brand.
Read more on MKC →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
